Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its products includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. Neurotech International Limited was incorporated in 2016 and is based in Nedlands, Australia.
| Market Capitalization | $59.1147 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | |
| Book Value | 0.005 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.01 |
| EBITDA | -7,849.755 |
| Profit Margin | 0 |
| Operating Margin TTM | -6.5731 |
| Return on Assets TTM | -1.3386 |
| Return on Equity TTM | -2.8902 |
| Revenue TTM | 1,194.488 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2015-12-31 | 215.231 | 114.679 | 100.552 | 1,122.291 |
| 2016-06-30 | 160.06 | 47.34 | 112.72 | 2,611.209 |
| 2017-06-30 | 88.31 | 80.542 | 7.768 | 3,959.514 |
| 2018-06-30 | 29.277 | 87.038 | -57.761 | 3,844.757 |
| 2019-06-30 | 197.546 | 449.508 | -251.962 | 2,592.212 |
| 2020-06-30 | 80.341 | 54.894 | 25.447 | 1,316.967 |
| 2021-06-30 | 206.367 | -20.34 | 226.707 | 7,674.93 |
| 2022-06-30 | 38.285 | 34.049 | 4.236 | 3,934.927 |
| 2023-06-30 | 5.959 | 0 | 5.959 | 9,055.031 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2015-12-31 | 1,881.635 | 3,283.043 | 1,988.365 | 120.418 | 377.413 | 2,621.963 |
| 2016-06-30 | 6,511.449 | 15,373.672 | 893.122 | 61.709 | 323.9 | 10,808.994 |
| 2017-06-30 | 2,637.363 | 4,952.166 | 657.038 | 129.866 | 244.937 | 10,354.758 |
| 2018-06-30 | 2,212.737 | 4,606.732 | 375.66 | 29.788 | 0 | 14,309.941 |
| 2019-06-30 | 474.682 | 652.748 | 355.335 | 126.075 | 15,099.925 | |
| 2020-06-30 | 12.358 | 80.805 | 727.098 | 46.582 | 15,498.123 | |
| 2021-06-30 | 4,827.37 | 5,005.884 | 1,144.418 | 0 | 25,750.378 | |
| 2022-06-30 | 1,895.431 | 2,022.971 | 592.98 | 0 | 25,776.778 | |
| 2023-06-30 | 5,025.795 | 5,308.83 | 1,346.867 | 0 | 34,350.859 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2015-12-31 | -839.413 | -851.21 | 1,879.595 | |||
| 2016-06-30 | -2,792.523 | -785.79 | -874.1 | 1,007.536 | ||
| 2017-06-30 | -4,031.79 | -3,120.973 | 1,629.827 | 1,007.536 | 2,637.363 | |
| 2018-06-30 | -3,990.293 | -3,025.662 | -424.626 | 2,637.363 | 2,212.737 | |
| 2019-06-30 | -6,812.462 | -2,543.052 | -1,738.055 | 2,212.737 | 474.682 | |
| 2020-06-30 | -2,134.684 | -682.831 | -462.324 | 474.682 | 12.358 | |
| 2021-06-30 | -7,411.458 | -2,316.528 | 4,815.012 | 12.358 | 4,827.37 | |
| 2022-06-30 | -3,363.61 | -3,363.022 | -2,931.939 | 4,827.37 | 1,895.431 | |
| 2023-06-30 | -7,791.939 | -6,316.96 | 3,130.364 | 1,895.431 | 5,025.795 |